Use of mTOR inhibitors in the treatment of breast cancer: an evaluation of factors that influence patient outcomes

Overview of attention for article published in Breast cancer targets and therapy, April 2014

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 39 Dimensions

Readers on

mendeley: 86 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 39 publications that cite this research output.

39

The most recent citing publications are shown below. View all 39 publications that cite this research output on Dimensions.

The Therapeutic Efficacy and Mechanism of Action of Gnetin C, a Natural Compound from the Melinjo Plant, in a Preclinical Mouse Model of Advanced Prostate Cancer

Article in Cancers (March 2024)

Designing of target‐specific N‐substituted tetrahydroquinoline derivatives as potent mTOR inhibitors via integrated structure‐guided computational approaches

Article in ChemistrySelect (February 2024)

Investigation of morpholine isosters for the development of a potent, selective and metabolically stable mTOR kinase inhibitor

Article in European Journal of Medicinal Chemistry (December 2022)